Broader indices haven't been performing very well since the Fed's not so surprise revelation about the number of expected cuts in 2025. Nevertheless, several stocks on Thursday posted notable gains. Let's take a look:
10. Summit Therapeutics Inc. (SMMT)
Shares of Summit Therapeutics (SMMT) on Thursday closed higher by 8.36 percent at $18.40 apiece as traders took heart from news that the company—in partnership with Chinese biotech Akeso—is developing a lung cancer treatment drug called ivonescimab, in hopes of bringing the lung cancer treatment drug to the market outside of Asia.
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.